- Oops!Something went wrong.Please try again later.
DGAP-News: Alzchem Group AG / Key word(s): Miscellaneous
Alzchem Group AG: Increase of free float to 47.5%
Alzchem Group AG welcomes both the increase in the free float to 47.5% and LIVIA's continued commitment to the company. It is convinced that both will have a positive effect on the perception of Alzchem shares on the capital market.
The company sees interesting growth prospects for itself especially in the areas of human and animal nutrition and agriculture. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and our creatine products can contribute to healthy aging as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective.
The broad product range of Alzchem Group AG includes dietary supplements, precursors for corona tests and pharmaceutical raw materials. These products are our company's response to global trends and developments. Alzchem is ideally positioned in this regard and sees itself as well equipped for an environmentally oriented future and global developments.
The company employs around 1,630 people at four production sites in Germany and one plant in Sweden, as well as two sales companies in the USA and China. In 2020, Alzchem generated consolidated sales of around EUR 379 million and EBITDA of around EUR 53.8 million.
17.11.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
Alzchem Group AG
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart
EQS News ID:
End of News
DGAP News Service